Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 01-Feb-24 4:47 PM View:  | Arrivent Biopharma, Inc. (AVBP) | 30-Jan-24 | Conversion | 3,929,120 | -- | -- | 100% 0 to 3.93M | |
| 01-Feb-24 4:47 PM View: | Arrivent Biopharma, Inc. (AVBP) | 30-Jan-24 | Purchase | 555,555 | $18.00 | $9,999,990.00 | 14% 3.93M to 4.48M | |
| 27-Oct-21 4:20 PM View: | Enfusion, Inc. (ENFN) | 25-Oct-21 | Sale | 647,862 | $15.90 | $10,297,800.00 | (12%) 5.62M to 4.98M | |
| 15-Nov-17 4:32 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 13-Nov-17 | Conversion | 2,098,580 | -- | -- | 100% 2.1M to 4.2M | |
| 15-Nov-17 4:32 PM View: | Apellis Pharmaceuticals, Inc. (APLS) | 13-Nov-17 | Purchase | 1,428,570 | $14.00 | $20,000,000.00 | 34% 4.2M to 5.63M | |
| 10-Feb-16 10:00 PM View: | Beigene, Ltd. (BGNE) | 08-Feb-16 | Conversion | 30,626,800 | -- | -- | 100% 30.63M to 61.25M | |
| 10-Feb-16 10:00 PM View: | Beigene, Ltd. (BGNE) | 08-Feb-16 | Purchase | 9,100,000 | -- | -- | 15% 61.25M to 70.35M |